Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2006
12/28/2006WO2006137515A1 Therapeutic agent for cancer comprising polypeptide capable of inhibiting the function of synoviolin as active ingredient
12/28/2006WO2006137514A1 Therapeutic agent for cancer comprising substance capable of inhibiting expression or function of synoviolin as active ingredient and screening method for the therapeutic agent for cancer
12/28/2006WO2006137513A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006WO2006137510A1 Agent for reduction of bleeding in cerebrovascular disorder
12/28/2006WO2006137469A1 Metabotropic glutamate receptor activator
12/28/2006WO2006137465A1 Nitrogenated heterocyclic derivative
12/28/2006WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof
12/28/2006WO2006137441A1 Anti-fatigue composition
12/28/2006WO2006137435A1 Agonist to g protein-coupled receptor g2a and method of screening g2a activity controller
12/28/2006WO2006137421A1 Agent for topical administration
12/28/2006WO2006137377A1 Neuronal regeneration promoter
12/28/2006WO2006137368A1 Preventive or remedy for glaucoma
12/28/2006WO2006137350A1 Novel furopyridine derivative, pharmaceutical composition comprising the derivative, and use of the derivative or composition
12/28/2006WO2006137341A1 Agent for visualizing vitreous body
12/28/2006WO2006137314A1 Radial brush
12/28/2006WO2006099480A3 Stress proteins and peptides and methods of use thereof
12/28/2006WO2006081251A3 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
12/28/2006US20060293519 Method for producing cyclic diamine derivative or salt thereof
12/28/2006US20060293507 Crystallization of IGF-1
12/28/2006US20060293391 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/28/2006US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases
12/28/2006US20060293371 Prodrug and process for producing the same
12/28/2006US20060293363 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
12/28/2006US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/28/2006US20060293347 Pharmaceutically active compounds
12/28/2006US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase
12/28/2006US20060293333 Therapeutic amides
12/28/2006US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006US20060293323 Therapeutic Combinations of erb B Kinase Inhibitors and Antineoplastic Therapies
12/28/2006US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
12/28/2006US20060293297 Cyanofluoropyrrolidine derviative
12/28/2006US20060293275 Hgf production accelerator containing heparin-like oligosaccharide
12/28/2006US20060293256 Remedy or preventive for kidney disease and method of diagnosing kidney disease
12/28/2006US20060293254 Podophyllotoxin
12/28/2006US20060293230 Expression and secretion of icIL-1 receptor antagonist type II
12/28/2006US20060293221 Mucosal repair by TFF2 peptides
12/28/2006US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection
12/28/2006US20060292655 2-O sulfatase compositions and methods of analyzing therewith
12/28/2006US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases
12/28/2006US20060292644 Novel tumor-associated marker
12/28/2006US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception
12/28/2006US20060292145 Human antihuman interleukin-18 antibody, fragment thereof and method for using same
12/28/2006US20060292133 Use of lactobacillus salivarius
12/28/2006US20060292130 2-O sulfatase nucleic acid compositions
12/28/2006CA2614111A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof
12/28/2006CA2613244A1 Vitreous body visualization agent
12/28/2006CA2612941A1 Method for the potentiation of opioid analgesics effects on pain
12/27/2006EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof
12/27/2006EP1736478A1 Methods and compositions for treating flaviviruses and pestiviruses
12/27/2006EP1736474A1 Piperidine derivative
12/27/2006EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators
12/27/2006EP1736467A1 Novel sulfonamide derivative
12/27/2006EP1736465A1 Aniline derivatives
12/27/2006EP1736169A1 Anticancer activity enhancer of viral therapy and method of cancer prevention or treatment
12/27/2006EP1736155A1 Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
12/27/2006EP1736153A2 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd)
12/27/2006EP1736151A2 Pharmaceutical composition for the therapy of lower urinary tract symptoms
12/27/2006EP1735323A1 Synthetic membrane anchors
12/27/2006EP1734985A2 Methods for suppressing neovascularization using ephrinb2
12/27/2006EP1534717B1 Beta-lactamase inhibitor prodrug
12/27/2006EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
12/27/2006EP1483264B1 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine
12/27/2006EP1480961B1 Glutaminyl based dpiv inhibitors
12/27/2006EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/27/2006EP1440159B1 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
12/27/2006EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors
12/27/2006EP1430051B1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds
12/27/2006EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
12/27/2006EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/27/2006EP1404704B1 Bridged bicyclic serine protease inhibitors
12/27/2006EP1397380B1 Multiple antigenic peptide displaying multiple copies of an epitope of a plaque-forming polypeptide and methods of using same
12/27/2006EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids
12/27/2006EP1390344B1 Benzamidoacetonitrile derivatives and their use as antiparasitics
12/27/2006EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
12/27/2006EP1368317B1 Tryptase inhibitors
12/27/2006EP1358209B1 Crystallization of igf-1
12/27/2006EP1354047B1 Methods for screening compounds that modulate lipid metabolism
12/27/2006EP1345895B1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
12/27/2006EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use
12/27/2006EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/27/2006EP1183362B1 Il-1 eta dna and polypeptides
12/27/2006EP1073739B1 Cd40-interacting and traf-interacting proteins
12/27/2006EP1034273B1 Histamine and serotonin binding molecules
12/27/2006EP1021410B1 Prostaglandin agonists and their use to treat bone disorders
12/27/2006EP0844875B1 Use of basic l-carnitine and acyl derivatives for lowering ceramide levels
12/27/2006CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006CN1886385A Crystals of phenylalanine derivatives and production methods thereof
12/27/2006CN1886375A Piperidine compound and method for producing same
12/27/2006CN1886150A Fibroblast-mobilizing agent containing g-csf and wound remedy
12/27/2006CN1886135A Phenyl-piperazine derivatives as modulators of muscarinic receptors
12/27/2006CN1884261A Hydantion method compolete preparation of chromium selenomethionine compounds (III) and its uses
12/27/2006CN1883685A Nano Chinese medicinal preparation of 'An Gong Niu Huang Wan' and preparation method thereof
12/27/2006CN1883665A Orally administered tablet, capsule, pills with eight ingredients and preparation method thereof
12/27/2006CN1883629A Compound Chinese medicinal ointment for regulating yin-yang equilibrium
12/27/2006CN1883615A Preparation method of sobering liquid and sobering liquid prepared thereby
12/27/2006CN1883573A Chinese medicinal preparation for treating finger tip injury
12/27/2006CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient